U.S. markets open in 5 hours 17 minutes
  • S&P Futures

    3,744.75
    +54.50 (+1.48%)
     
  • Dow Futures

    29,907.00
    +369.00 (+1.25%)
     
  • Nasdaq Futures

    11,493.75
    +208.00 (+1.84%)
     
  • Russell 2000 Futures

    1,745.00
    +30.10 (+1.76%)
     
  • Crude Oil

    83.84
    +0.21 (+0.25%)
     
  • Gold

    1,716.90
    +14.90 (+0.88%)
     
  • Silver

    21.01
    +0.43 (+2.07%)
     
  • EUR/USD

    0.9879
    +0.0052 (+0.53%)
     
  • 10-Yr Bond

    3.6510
    0.0000 (0.00%)
     
  • Vix

    29.31
    -2.31 (-7.31%)
     
  • GBP/USD

    1.1392
    +0.0072 (+0.64%)
     
  • USD/JPY

    144.6460
    +0.0260 (+0.02%)
     
  • BTC-USD

    20,053.88
    +871.98 (+4.55%)
     
  • CMC Crypto 200

    455.50
    +20.14 (+4.63%)
     
  • FTSE 100

    6,993.48
    +84.72 (+1.23%)
     
  • Nikkei 225

    26,992.21
    +776.42 (+2.96%)
     

10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

·2 min read

PLEASANTON, Calif., Sept. 2, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference in New York, New York.

10x Genomics Logo (PRNewsfoto/10x Genomics, Inc.)
10x Genomics Logo (PRNewsfoto/10x Genomics, Inc.)

10x Genomics' management is scheduled to participate in a fireside chat on Tuesday, September 13, at 10:35 a.m. Eastern Time.  Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: https://investors.10xgenomics.com/.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2021 based on publications and all of the top 20 global pharmaceutical companies by 2021 research and development spend and have been cited in over 3,800 research papers on discoveries ranging from oncology to immunology and neuroscience. Our patent portfolio comprises more than 1,500 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts 
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference-301616861.html

SOURCE 10x Genomics, Inc.